have shown synergistic increases in BMD with combination of PTH with IV BP For all adults with moderate fracture risk, we conditionally recommend oral or IV BP, PTH/PTHrP, or DEN over no treatment (PICO 1.4b-1.28.b, 2.4b,c-2. 17b, c In all adults with moderate fracture risk, we conditionally recommend against ROM and RAL therapies except in those intolerant of other OP medications, due to possible lifethreatening harms, including thrombosis, fatal stroke, major cardiovascular events, and death